Nanobac Pharmaceuticals, Incorporated
NNBP
$0.00
$0.000.00%
OTC PK
| 12/31/2007 | 09/30/2007 | 06/30/2007 | 03/31/2007 | 12/31/2006 | |
|---|---|---|---|---|---|
| Net Income | -32.23% | -48.04% | -50.73% | -100.11% | -34.88% |
| Total Depreciation and Amortization | -14.96% | -24.76% | -32.11% | -38.19% | -28.78% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 128.99% | 145.85% | 144.53% | 428.13% | 89.08% |
| Change in Net Operating Assets | 416.55% | 9,506.29% | 436.05% | 988.79% | 243.95% |
| Cash from Operations | 64.76% | 41.62% | 13.90% | -2.81% | -9.28% |
| Capital Expenditure | 88.19% | 74.80% | -51.47% | 1.89% | 68.80% |
| Sale of Property, Plant, and Equipment | -- | -200.00% | -150.77% | -150.77% | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 1,955.56% | 1,966.67% | 1,966.67% | 1,966.67% | -- |
| Cash from Investing | 413.55% | 578.82% | 1,323.33% | 638.24% | 61.92% |
| Total Debt Issued | -66.79% | -47.98% | -27.25% | -39.10% | 25.51% |
| Total Debt Repaid | -- | 100.00% | 100.00% | 68.25% | -129.49% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -66.12% | -46.81% | -26.00% | -38.39% | 15.60% |
| Foreign Exchange rate Adjustments | -44.92% | -735.71% | -263.13% | -209.85% | -181.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -216.72% | -211.78% | -213.77% | -201.22% | 438.89% |